Trial intelligence / Profile preview

Entecavir vs Lamivudine in HBV-related Advanced Liver Disease

NCT00823550Phase 4Unknown

Sponsor
Yonsei University
Start
Jan 2009
Primary completion
Jul 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of entecavir in hepatitis B (HBV), sponsored by Yonsei University. Status: unknown.

02

Drugs

entecavir
03

Conditions

hepatitis B (HBV)

Beyond the preview

Go deeper on NCT00823550.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00823550.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call